In order to successfully establish a latent infection, HCMV must enter CD34+ HPCs, maintain its genome, and simultaneously support essential cellular functions to avoid cell death and detection by the innate and adaptive immune responses. The gene discussed is CD34; the disease is disease arising from reactivation of latent virus.